Alemayehu Tinsae, Buonsenso Danilo
American Medical Center, Addis Ababa, Ethiopia.
St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Front Pediatr. 2022 Oct 13;10:991142. doi: 10.3389/fped.2022.991142. eCollection 2022.
Trisomy 21 (Down syndrome) is a chromosomal disorder associated with humoral and cellular immunologic impairments among other systemic manifestations. It occurs at a frequency of 1 in 750 live births. There are increasing reports of children with Down syndrome presenting signs of severe COVID-19. The literature from Africa on pediatric COVID-19 and risk stratification for severe disease is scant. A summary of the clinical features, complications, and treatment outcomes of three Ethiopian children with Trisomy 21 and severe COVID-19 along with a discussion of the correlation between trisomy 21 immunology and severe SARS CoV-2 infection is presented.
21三体综合征(唐氏综合征)是一种染色体疾病,除了其他全身表现外,还与体液和细胞免疫损伤有关。其发生率为每750例活产中有1例。越来越多的报告称,唐氏综合征患儿出现了严重COVID-19的症状。非洲关于儿童COVID-19和严重疾病风险分层的文献很少。本文总结了三名患有21三体综合征和严重COVID-19的埃塞俄比亚儿童的临床特征、并发症和治疗结果,并讨论了21三体综合征免疫学与严重SARS-CoV-2感染之间的相关性。